Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on healthcare issues. In his interview of Mr. Proulx, Henry Acosta of Health Professional Radio draws out descriptions of the key elements of Imagion Biosystems’ MagSense® cancer detection technology, the company’s commercialization plan, and what motivates Mr. Proulx and the company’s employees, collaborators, and investors to get MagSense® technology into hospitals and medical clinics just as soon as possible.
Listen to the eight-minute audio file here:
Corporate Update – IND for MagSense® HER2 Phase 2 Study Immediate Priority
November 14, 2024
Corporate Updates: $3M fundraising led by CPS Capital to be completed in early December Filing of IND for MagSense® HER2 Phase 2 Study Immediate Priority